Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nextedia | ALNXT | 4. nov 2024 | 0.43 | -6.67 |
NFL Biosciences S.A. | ALNFL | 4. nov 2024 | 2.29 | +6.02 |
NHOA | NHOA | 4. nov 2024 | 1.26 | +0.16 |
Nicolas Miguet and Associes S.A | MLNMA | 4. nov 2024 | 0.12 | 0.00 |
Nicox SA | ALCOX | 4. nov 2024 | 0.25 | -1.61 |
Nokia | NOKIA | 4. nov 2024 | 4.32 | -0.96 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NBA | 4. nov 2024 | 5.80 | -1.69 |
Novacyt | ALNOV | 4. nov 2024 | 0.64 | -3.60 |
Novatech Industries | MLNOV | 4. nov 2024 | 10.50 | 0.00 |
NR 21 | NR21 | 4. nov 2024 | 35.60 | +0.57 |
NRJ Group | NRG | 4. nov 2024 | 7.44 | +0.54 |
NSC Groupe | ALNSC | 4. nov 2024 | 67.50 | 0.00 |
NSE SA | ALNSE | 4. nov 2024 | 29.70 | -0.34 |
Obiz | ALBIZ | 4. nov 2024 | 5.14 | +0.39 |
Oeneo | SBT | 4. nov 2024 | 9.78 | -1.01 |
Omer-Decugis & Cie | ALODC | 4. nov 2024 | 4.58 | -0.87 |
Oncodesign Precision Medicine S.A | ALOPM | 4. nov 2024 | 1.13 | -1.74 |
One Experience | ALEXP | 4. nov 2024 | 0.33 | 0.00 |
Onlineformapro | MLONL | 4. nov 2024 | 2.12 | -7.02 |
OPmobility | OPM | 4. nov 2024 | 8.98 | +0.79 |
Orange. | ORA | 4. nov 2024 | 10.10 | +0.40 |
Orapi | ORAP | 4. nov 2024 | 6.46 | 0.00 |
Ordissimo | ALORD | 4. nov 2024 | 0.69 | -1.70 |
Orege | OREGE | 4. nov 2024 | 0.35 | +5.71 |
OSE Immunotherapeutics | OSE | 4. nov 2024 | 10.74 | +4.88 |
Osmosun S.A | ALWTR | 4. nov 2024 | 2.11 | +6.96 |
OVH GROUPE (PROM.)EO 1 | OVH | 4. nov 2024 | 8.52 | -2.63 |
Pacte Novation | MLPAC | 4. nov 2024 | 8.20 | 0.00 |
Paref | PAR | 4. nov 2024 | 40.00 | 0.00 |
Parrot | PARRO | 4. nov 2024 | 1.92 | +0.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.